Hepatitis B surface antigen (HBsAg) prevalence (%) in Azerbaijan
Azerbaijan: Hepatitis B surface antigen (HBsAg) prevalence was 0.3% in 2024. ▲ Rising
Hepatitis B surface antigen (HBsAg) prevalence in Azerbaijan, 2015–2024
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for hepatitis b surface antigen (hbsag) prevalence in Azerbaijan is 0.3%, measured in 2024. That is the highest value across all 10 years on record.
That represents a change of up 50.0% over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Azerbaijan peaked at 0.3% in 2022 and was at its lowest, 0.2%, in 2015.
That places Azerbaijan 71st out of 194 countries with data for 2024, putting it in the middle of the range.
Hepatitis B surface antigen (HBsAg) prevalence in Azerbaijan, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 0.2% | — |
| 2016 | 0.2% | +0.0% |
| 2017 | 0.2% | +0.0% |
| 2018 | 0.2% | +0.0% |
| 2019 | 0.2% | +0.0% |
| 2020 | 0.2% | +0.0% |
| 2021 | 0.2% | +0.0% |
| 2022 | 0.3% | +50.0% |
| 2023 | 0.3% | +0.0% |
| 2024 | 0.3% | +0.0% |
Azerbaijan compared with similar countries
- Azerbaijan's 0.3% is above the median for upper middle income countries, which is 0.2%, 1.5× the median. (57 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 0.2% | 0.2% | 0.2% | 5 |
| 2020s | 0.3% | 0.2% | 0.3% | 5 |
Countries ranked near Azerbaijan
More health data for Azerbaijan
- Un projection of annual infant deaths, annual growth rate -1.12 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.1127 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,241 deaths per 1,000 people (2090)
- Number of infants who die before age 1 264 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -3.72 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0286 units per person (2025)
- Population ages 00-04, male, annual growth rate -4.06 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in Azerbaijan?
- Hepatitis b surface antigen (hbsag) prevalence in Azerbaijan was 0.3% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Azerbaijan?
- The highest recorded value was 0.3% in 2022.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Azerbaijan?
- The lowest recorded value was 0.2% in 2015.
- How does Azerbaijan rank for hepatitis b surface antigen (hbsag) prevalence?
- Azerbaijan ranks 71st out of 194 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Azerbaijan?
- Over the last ten years it is up 50.0%. The long-run trend across the full record is rising.
- Where does this Azerbaijan data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).